{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:10:51Z","timestamp":1789589451238,"version":"build-2803163510"},"reference-count":163,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jpha.2024.101057","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:15:02Z","timestamp":1722888902000},"page":"101057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nose to brain strategy coupled to nano vesicular system for natural products delivery: Focus on synaptic plasticity in Alzheimer's disease"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4634-1684","authenticated-orcid":false,"given":"Nunzia","family":"Maisto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3358-4068","authenticated-orcid":false,"given":"Dalila","family":"Mango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2024.101057_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/ddc3010011","article-title":"Plant-Derived Natural Products: A source for drug discovery and development","volume":"3","author":"Chaachouay","year":"2024","journal-title":"Drugs Drug Candidates"},{"key":"10.1016\/j.jpha.2024.101057_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/08923970903296136","article-title":"Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders","volume":"32","author":"Villa","year":"2010","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.jpha.2024.101057_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1011740","article-title":"Natural product-based pharmacological studies for neurological disorders","volume":"13","author":"Puri","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101057_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6262316","article-title":"Natural bioactive products with antioxidant properties useful in neurodegenerative diseases 2020","volume":"2021","author":"Mendon\u00e7a-Junior","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jpha.2024.101057_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","article-title":"Crossing the blood-brain barrier: Recent advances in drug delivery to the brain","volume":"31","author":"Patel","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpha.2024.101057_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood-brain barrier: The role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jpha.2024.101057_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood-brain barrier structure and function and the challenges for CNS drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jpha.2024.101057_bib8","first-page":"39","article-title":"Structural and functional aspects of the blood-brain barrier","volume":"61","author":"Begley","year":"2003","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.jpha.2024.101057_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","article-title":"The neurovascular unit coming of age: A journey through neurovascular coupling in health and disease","volume":"96","author":"Iadecola","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.jpha.2024.101057_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: New opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpha.2024.101057_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jpha.2024.101057_bib12","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"Schinkel","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpha.2024.101057_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/153537020523000206","article-title":"Modulation of p-glycoprotein transport function at the blood-brain barrier","volume":"230","author":"Bauer","year":"2005","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.jpha.2024.101057_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"L\u00f6scher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jpha.2024.101057_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112599","article-title":"Non-invasive drug delivery across the blood-brain barrier: A prospective analysis","volume":"15","author":"Niazi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpha.2024.101057_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2014.01.008","article-title":"Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system","volume":"72","author":"Aryal","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpha.2024.101057_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111829","article-title":"Systematic development of lectin conjugated microspheres for nose-to-brain delivery of rivastigmine for the treatment of Alzheimer\u2019s disease","volume":"141","author":"Gao","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpha.2024.101057_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122588","article-title":"Nose-to-brain delivery of galantamine loaded nanospray dried polyacrylic acid\/taurodeoxycholate mixed matrix as a protective therapy in lipopolysaccharide-induced Alzheimer\u2019s in mice model","volume":"632","author":"Elhabak","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpha.2024.101057_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ph15030281","article-title":"Lipid nanocarriers overlaid with chitosan for brain delivery of berberine via the nasal route","volume":"15","author":"Abo El-Enin","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpha.2024.101057_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejpb.2014.02.007","article-title":"Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)-block-poly(d,l)-lactic-co-glycolic acid (PEG-PLGA) nanoparticles for the treatment of schizophrenia","volume":"87","author":"Piazza","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpha.2024.101057_bib21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/ph5101092","article-title":"Intranasal delivery of camptothecin-loaded Tat-modified nanomicells for treatment of intracranial brain tumors","volume":"5","author":"Taki","year":"2012","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpha.2024.101057_bib22","first-page":"673","article-title":"Nose to brain targeted drug therapy: A review, Saudi J.","volume":"6","author":"Vani","year":"2020","journal-title":"Med. Pharm. Sci."},{"key":"10.1016\/j.jpha.2024.101057_bib23","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4103\/1673-5374.241458","article-title":"Nose-to-brain drug delivery approach: A key to easily accessing the brain for the treatment of Alzheimer\u2019s disease","volume":"13","author":"Alexander","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jpha.2024.101057_bib24","first-page":"205","article-title":"Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil","volume":"10","author":"Al Asmari","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jpha.2024.101057_bib25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: How, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jpha.2024.101057_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020038","article-title":"Chitosan glutamate-coated niosomes: A proposal for nose-to-brain delivery","volume":"10","author":"Rinaldi","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpha.2024.101057_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2018.12.007","article-title":"inPentasomes: An innovative nose-to-brain pentamidine delivery blunts MPTP Parkinsonism in mice","volume":"294","author":"Rinaldi","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpha.2024.101057_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.044","article-title":"Stimuli-responsive in situ gelling system for nose-to-brain drug delivery","volume":"327","author":"Agrawal","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpha.2024.101057_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071805","article-title":"Intranasal nanotransferosomal gel for quercetin brain targeting: I. optimization, characterization, brain localization, and cytotoxic studies","volume":"15","author":"Elkomy","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpha.2024.101057_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-5173(99)00392-0","article-title":"Nasal absorption of (S)-UH-301 and its transport into the cerebrospinal fluid of rats","volume":"195","author":"Dahlin","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpha.2024.101057_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ph16101424","article-title":"Liposome-derived nanosystems for the treatment of behavioral and neurodegenerative diseases: The promise of niosomes, transfersomes, and ethosomes for increased brain drug bioavailability","volume":"16","author":"Pires","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpha.2024.101057_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/469679","article-title":"Liposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer\u2019s disease and Parkinson\u2019s disease)","volume":"2011","author":"Spuch","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jpha.2024.101057_bib33","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/acs.bioconjchem.2c00376","article-title":"Spotlight on photoactivatable liposomes beyond drug delivery: An enabler of multitargeting of molecular pathways","volume":"33","author":"Saad","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jpha.2024.101057_bib34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbrc.2010.03.024","article-title":"Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis","volume":"394","author":"Tamaru","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpha.2024.101057_bib35","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1476-5381.2012.02103.x","article-title":"The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases in vitro drug delivery across blood-brain barrier cells","volume":"167","author":"Pinz\u00f3n-Daza","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101057_bib36","article-title":"Cell-penetrating peptide and transferrin co-modified liposomes for targeted therapy of glioma","volume":"24","author":"Wang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jpha.2024.101057_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102237","article-title":"Blood-brain barrier transport of transferrin receptor-targeted nanoparticles","volume":"14","author":"Thomsen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpha.2024.101057_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10611861003734001","article-title":"Targeting the insulin receptor: Nanoparticles for drug delivery across the blood-brain barrier (BBB)","volume":"19","author":"Ulbrich","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jpha.2024.101057_bib39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jps.23836","article-title":"Nose-to-brain delivery: Evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake","volume":"103","author":"Musumeci","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpha.2024.101057_bib40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2174\/1567201812666150507120124","article-title":"Nose to brain delivery of midazolam loaded PLGA nanoparticles: in vitro and in vivo investigations","volume":"13","author":"Sharma","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jpha.2024.101057_bib41","article-title":"The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters","volume":"21","author":"Chung","year":"2023","journal-title":"Epilepsy Behav. Rep."},{"key":"10.1016\/j.jpha.2024.101057_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030588","article-title":"Strategies to improve drug strength in nasal preparations for brain delivery of low aqueous solubility drugs","volume":"14","author":"Pires","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpha.2024.101057_bib43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40263-022-00930-4","article-title":"Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: Rationale, successes, and future needs","volume":"36","author":"Lofts","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpha.2024.101057_bib44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s12035-012-8324-3","article-title":"Targeting synaptic dysfunction in Alzheimer\u2019s disease therapy","volume":"46","author":"Nistic\u00f2","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpha.2024.101057_bib45","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1074\/mcp.RA118.001290","article-title":"Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer\u2019s disease cerebrospinal fluid","volume":"18","author":"Lle\u00f3","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jpha.2024.101057_bib46","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jpha.2024.101057_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001694","article-title":"If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?","volume":"20","author":"Haass","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jpha.2024.101057_bib48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jpha.2024.101057_bib49","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","article-title":"Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state","volume":"13","author":"Pike","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpha.2024.101057_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11051411","article-title":"The roles of the amyloid beta monomers in physiological and pathological conditions","volume":"11","author":"Schreiner","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpha.2024.101057_bib51","article-title":"Synaptic plasticity in the hippocampal slice preparation","volume":"Chapter 6","author":"Bortolotto","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.jpha.2024.101057_bib52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","article-title":"LTP and LTD","volume":"44","author":"Malenka","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.jpha.2024.101057_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.npp.1301559","article-title":"Synaptic plasticity: Multiple forms, functions, and mechanisms","volume":"33","author":"Citri","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpha.2024.101057_bib54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuropharm.2013.10.018","article-title":"Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment","volume":"79","author":"Counts","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpha.2024.101057_bib55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jnc.15007","article-title":"A mechanistic hypothesis for the impairment of synaptic plasticity by soluble A\u03b2 oligomers from Alzheimer\u2019s brain","volume":"154","author":"Li","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpha.2024.101057_bib56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41386-022-01370-w","article-title":"Synaptic plasticity and mental health: Methods, challenges and opportunities","volume":"48","author":"Appelbaum","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpha.2024.101057_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jpha.2024.101057_bib58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbi.2022.10.009","article-title":"Prevention of microgliosis halts early memory loss in a mouse model of Alzheimer\u2019s disease","volume":"107","author":"Kater","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpha.2024.101057_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2303","article-title":"Synaptic plasticity, memory and the hippocampus: A neural network approach to causality","volume":"9","author":"Neves","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jpha.2024.101057_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00266","article-title":"Hippocampal deficits in amyloid-\u03b2-related rodent models of Alzheimer\u2019s disease","volume":"14","author":"Vyas","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jpha.2024.101057_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00401","article-title":"Ginkgolic acid protects against A\u03b2-induced synaptic dysfunction in the hippocampus","volume":"7","author":"Mango","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101057_bib62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.phrs.2018.03.016","article-title":"Role of ASIC1a in A\u03b2-induced synaptic alterations in the hippocampus","volume":"131","author":"Mango","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jpha.2024.101057_bib63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0896-6273(00)81067-3","article-title":"Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization","volume":"25","author":"Man","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jpha.2024.101057_bib64","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1073\/pnas.051634698","article-title":"Insulin promotes rapid delivery of N-methyl-d-aspartate receptors to the cell surface by exocytosis","volume":"98","author":"Skeberdis","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jpha.2024.101057_bib65","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1046\/j.1471-4159.1999.721523.x","article-title":"Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus","volume":"72","author":"Christie","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpha.2024.101057_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12934","article-title":"Intranasal insulin","volume":"33","author":"Hallschmid","year":"2021","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.jpha.2024.101057_bib67","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s13346-024-01558-1","article-title":"Insulin delivery to the brain via the nasal route: Unraveling the potential for Alzheimer\u2019s disease therapy","volume":"14","author":"Wong","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jpha.2024.101057_bib68","article-title":"Protective effects of oral vitamin C on memory and learning impairment and attenuation of synaptic plasticity induced by intracerebroventricular injection of Beta-amyloid peptide in male rats","author":"Sattari","year":"2021","journal-title":"Research Square."},{"key":"10.1016\/j.jpha.2024.101057_bib69","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.tiv.2013.10.002","article-title":"Curcumin protects organotypic hippocampal slice cultures from A\u03b21\u201342-induced synaptic toxicity","volume":"27","author":"Hoppe","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.jpha.2024.101057_bib70","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neurobiolaging.2014.08.034","article-title":"Amyloid-\u03b2 pathology is attenuated by tauroursodeoxycholic acid treatment in APP\/PS1 mice after disease onset","volume":"36","author":"Dion\u00edsio","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jpha.2024.101057_bib71","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/hipo.20572","article-title":"Galantamine enhancement of long-term potentiation is mediated by calcium\/calmodulin-dependent protein kinase II and protein kinase C activation","volume":"19","author":"Moriguchi","year":"2009","journal-title":"Hippocampus"},{"key":"10.1016\/j.jpha.2024.101057_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ph15121469","article-title":"Pharmacological activities of ginkgolic acids in relation to autophagy","volume":"15","author":"Ding","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpha.2024.101057_bib73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/112_2020_45","article-title":"Role of ASIC1a in normal and pathological synaptic plasticity","volume":"177","author":"Mango","year":"2020","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101057_bib74","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuroscience.2016.08.051","article-title":"Resveratrol ameliorates spatial learning memory impairment induced by A\u03b21\u201342 in rats","volume":"344","author":"Wang","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpha.2024.101057_bib75","doi-asserted-by":"crossref","first-page":"153490","DOI":"10.1016\/j.phymed.2021.153490","article-title":"Rosmarinic acid and ursolic acid alleviate deficits in cognition, synaptic regulation and adult hippocampal neurogenesis in an A\u03b21\u221242-induced mouse model of Alzheimer's disease","volume":"83","author":"Mirza","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jpha.2024.101057_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuropharm.2016.04.032","article-title":"Quercetin stabilizes apolipoprotein E and reduces brain A\u03b2 levels in amyloid model mice","volume":"108","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpha.2024.101057_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020615","article-title":"Vitamin C-sources, physiological role, kinetics, deficiency, use, toxicity, and determination","volume":"13","author":"Dosed\u011bl","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jpha.2024.101057_bib78","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0166-2236(99)01543-X","article-title":"Ascorbate regulation and its neuroprotective role in the brain","volume":"23","author":"Rice","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jpha.2024.101057_bib79","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/1871527320666211119122150","article-title":"Role of vitamins in neurodegenerative diseases: A review, CNS Neurol.","volume":"21","author":"Kumar","year":"2022","journal-title":"Disord. Drug Targets"},{"key":"10.1016\/j.jpha.2024.101057_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/nu14030613","article-title":"Ascorbic acid reduces neurotransmission, synaptic plasticity, and spontaneous hippocampal rhythms in in vitro slices","volume":"14","author":"Heruye","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jpha.2024.101057_bib81","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JAD-2009-0923","article-title":"Ascorbic acid and rates of cognitive decline in Alzheimer\u2019s disease","volume":"16","author":"Bowman","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpha.2024.101057_bib82","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.foodchem.2016.10.012","article-title":"Factors that impact the stability of vitamin C at intermediate temperatures in a food matrix","volume":"220","author":"Herbig","year":"2017","journal-title":"Food Chem."},{"key":"10.1016\/j.jpha.2024.101057_bib83","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1080\/10408398.2015.1077195","article-title":"Curcumin, an active component of turmeric (Curcuma longa), and its effects on health","volume":"57","author":"Kocaadam","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.jpha.2024.101057_bib84","first-page":"177","article-title":"Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: Novel targets for neuroprotection in Alzheimer\u2019s disease, Ital.","volume":"52","author":"Calabrese","year":"2003","journal-title":"J. Biochem."},{"key":"10.1016\/j.jpha.2024.101057_bib85","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","article-title":"The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse","volume":"21","author":"Lim","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpha.2024.101057_bib86","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.lfs.2005.08.028","article-title":"Prevention of kainic acid-induced changes in nitric oxide level and neuronal cell damage in the rat hippocampus by manganese complexes of curcumin and diacetylcurcumin","volume":"78","author":"Sumanont","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.jpha.2024.101057_bib87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neulet.2010.05.062","article-title":"Potential protection of curcumin against intracellular amyloid beta-induced toxicity in cultured rat prefrontal cortical neurons","volume":"480","author":"Qin","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpha.2024.101057_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008643","article-title":"A new target for amyloid beta toxicity validated by standard and high-throughput electrophysiology","volume":"5","author":"Varghese","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2024.101057_bib89","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-6-63","article-title":"Alzheimer\u2019s disease: Synapses gone cold","volume":"6","author":"Koffie","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jpha.2024.101057_bib90","doi-asserted-by":"crossref","first-page":"14437","DOI":"10.1073\/pnas.1009268107","article-title":"CaMKII control of spine size and synaptic strength: Role of phosphorylation states and nonenzymatic action","volume":"107","author":"Pi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jpha.2024.101057_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2020.124862","article-title":"Modification of curcumin-loaded liposome with edible compounds to enhance ability of crossing blood brain barrier, Colloids Surf","volume":"599","author":"Chen","year":"2020","journal-title":"A Physicochem. Eng. Aspects"},{"key":"10.1016\/j.jpha.2024.101057_bib92","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9","article-title":"Ellagitannins - nature, occurrence and dietary burden","volume":"80","author":"Clifford","year":"2000","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.jpha.2024.101057_bib93","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0006-2952(03)00413-1","article-title":"Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid: Extensive binding to protein and DNA","volume":"66","author":"Whitley","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101057_bib94","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-2001-14306","article-title":"New antioxidant and antimicrobial ellagic acid derivatives from Pteleopsis hylodendron","volume":"67","author":"Atta-Ur-Rahman","year":"2001","journal-title":"Planta Med."},{"key":"10.1016\/j.jpha.2024.101057_bib95","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1080\/13880209.2017.1319867","article-title":"Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12\/IL-17\/IL-11 axis and restriction of mature oligodendrocytes apoptosis","volume":"55","author":"Sanadgol","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.jpha.2024.101057_bib96","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2174\/1381612822666160125114503","article-title":"Insights into effects of ellagic acid on the nervous system: A mini review","volume":"22","author":"Ahmed","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpha.2024.101057_bib97","doi-asserted-by":"crossref","DOI":"10.1186\/1743-7075-6-33","article-title":"Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice","volume":"6","author":"Chao","year":"2009","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.jpha.2024.101057_bib98","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lfs.2015.01.013","article-title":"Ellagic acid prevents cognitive and hippocampal long-term potentiation deficits and brain inflammation in rat with traumatic brain injury","volume":"124","author":"Farbood","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.jpha.2024.101057_bib99","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1471-4159.2000.0750634.x","article-title":"The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK","volume":"75","author":"Tancredi","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpha.2024.101057_bib100","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.psyneuen.2007.09.004","article-title":"A dual role for interleukin-1 in hippocampal-dependent memory processes","volume":"32","author":"Goshen","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpha.2024.101057_bib101","article-title":"Oral administration of ellagic acid mitigates perioperative neurocognitive disorders, hippocampal oxidative stress, and neuroinflammation in aged mice by restoring IGF-1 signaling","volume":"14","author":"Chen","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2024.101057_bib102","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00213-017-4589-6","article-title":"Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer\u2019s disease: An exploration of underlying mechanisms","volume":"234","author":"Kiasalari","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpha.2024.101057_bib103","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/jf8037105","article-title":"Enhanced oral bioavailability and antioxidant profile of ellagic acid by phospholipids","volume":"57","author":"Murugan","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jpha.2024.101057_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109191","article-title":"Malfunction of astrocyte and cholinergic input is involved in postoperative impairment of hippocampal synaptic plasticity and cognitive function","volume":"217","author":"Wang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpha.2024.101057_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030829","article-title":"Chitosan-based nanoparticles for targeted nasal galantamine delivery as a promising tool in Alzheimer\u2019s disease therapy","volume":"15","author":"Georgieva","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpha.2024.101057_bib106","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1089\/ars.2007.1761","article-title":"Mitochondrial cascade hypothesis of Alzheimer\u2019s disease: Myth or reality?","volume":"9","author":"Mancuso","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jpha.2024.101057_bib107","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2006-960467","article-title":"Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC\/MS","volume":"65","author":"Biber","year":"1999","journal-title":"Planta Med."},{"key":"10.1016\/j.jpha.2024.101057_bib108","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/dmd.112.049148","article-title":"Tariquidar and elacridar are dose-dependently transported by P-glycoprotein and Bcrp at the blood-brain barrier: A small-animal positron emission tomography and in vitro study","volume":"41","author":"Bankstahl","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpha.2024.101057_bib109","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ejpb.2014.06.012","article-title":"Cyclosporin A affects the bioavailability of ginkgolic acids via inhibition of P-gp and BCRP","volume":"88","author":"Li","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpha.2024.101057_bib110","doi-asserted-by":"crossref","first-page":"25116","DOI":"10.1074\/jbc.M003643200","article-title":"Isolation of a tarantula toxin specific for a class of proton-gated Na+ channels","volume":"275","author":"Escoubas","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2024.101057_bib111","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2174\/1381612828666220422084159","article-title":"Recent advances in acid-sensitive ion channels in central nervous system diseases","volume":"28","author":"Zhu","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpha.2024.101057_bib112","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2013.02.030","article-title":"Approaches for enhancing oral bioavailability of peptides and proteins","volume":"447","author":"Renukuntla","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpha.2024.101057_bib113","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.2010.05865.x","article-title":"Neuroprotective properties of resveratrol and derivatives","volume":"1215","author":"Richard","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpha.2024.101057_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00218","article-title":"Neuroprotective effects of resveratrol in Alzheimer disease pathology","volume":"6","author":"Rege","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpha.2024.101057_bib115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/15734064113096660053","article-title":"Chemistry, stability and bioavailability of resveratrol","volume":"10","author":"Francioso","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/j.jpha.2024.101057_bib116","article-title":"Tissue distribution of trans-resveratrol and its metabolites after oral administration in human eyes","volume":"2017","author":"Wang","year":"2017","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.jpha.2024.101057_bib117","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(02)02037-X","article-title":"Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice","volume":"449","author":"Takeda","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101057_bib118","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3109\/13880209.2015.1010738","article-title":"Rosmarinic acid exerts a neuroprotective effect in the kainate rat model of temporal lobe epilepsy: Underlying mechanisms","volume":"53","author":"Khamse","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.jpha.2024.101057_bib119","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lfs.2014.07.010","article-title":"Rosmarinic acid mediated neuroprotective effects against H2O2-induced neuronal cell damage in N2A cells","volume":"113","author":"Ghaffari","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.jpha.2024.101057_bib120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbrc.2016.04.153","article-title":"Acute rosmarinic acid treatment enhances long-term potentiation, BDNF and GluR-2 protein expression, and cell survival rate against scopolamine challenge in rat organotypic hippocampal slice cultures","volume":"475","author":"Hwang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpha.2024.101057_bib121","doi-asserted-by":"crossref","DOI":"10.1038\/srep00225","article-title":"NMDA receptors and BAX are essential for A\u03b2 impairment of LTP","volume":"2","author":"Olsen","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2024.101057_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45168-1","article-title":"Rosmarinic acid suppresses Alzheimer\u2019s disease development by reducing amyloid \u03b2 aggregation by increasing monoamine secretion","volume":"9","author":"Hase","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2024.101057_bib123","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijpharm.2017.05.039","article-title":"Targeted delivery of rosmarinic acid across the blood-brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E","volume":"528","author":"Kuo","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpha.2024.101057_bib124","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tifs.2016.07.004","article-title":"The biological activities, chemical stability, metabolism and delivery systems of quercetin: A review","volume":"56","author":"Wang","year":"2016","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.jpha.2024.101057_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010059","article-title":"Neuroprotective effects of quercetin in Alzheimer\u2019s disease","volume":"10","author":"Khan","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpha.2024.101057_bib126","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ptr.2902","article-title":"Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage-dependent sodium channels in hippocampal CA1 pyramidal neurons","volume":"24","author":"Yao","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.jpha.2024.101057_bib127","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000072357","article-title":"Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice","volume":"69","author":"Patil","year":"2003","journal-title":"Pharmacology"},{"key":"10.1016\/j.jpha.2024.101057_bib128","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s11064-014-1343-x","article-title":"Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer\u2019s disease","volume":"39","author":"Wang","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jpha.2024.101057_bib129","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.neurobiolaging.2015.05.006","article-title":"Quercetin reduces eIF2\u03b1 phosphorylation by GADD34 induction","volume":"36","author":"Hayakawa","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jpha.2024.101057_bib130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuropharm.2015.01.027","article-title":"The flavonoid quercetin ameliorates Alzheimer\u2019s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer\u2019s disease model mice","volume":"93","author":"Sabogal-Gu\u00e1queta","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpha.2024.101057_bib131","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.colsurfb.2016.08.052","article-title":"Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer\u2019s disease","volume":"148","author":"Sun","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.jpha.2024.101057_bib132","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7705\/biomedica.v38i0.3761","article-title":"Quercetin ameliorates inflammation in CA1 hippocampal region in aged triple transgenic Alzheimer\u00b4s disease mice model","volume":"38","author":"Vargas-Restrepo","year":"2018","journal-title":"Biomedica"},{"key":"10.1016\/j.jpha.2024.101057_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24122287","article-title":"Preventive effect of quercetin in a triple transgenic Alzheimer\u2019s disease mice model","volume":"24","author":"Paula","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jpha.2024.101057_bib134","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6038996","article-title":"Flavonoids as promising neuroprotectants and their therapeutic potential against Alzheimer\u2019s disease","volume":"2022","author":"Minocha","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jpha.2024.101057_bib135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-43345-w","article-title":"Quercetin conjugated with superparamagnetic iron oxide nanoparticles improves learning and memory better than free quercetin via interacting with proteins involved in LTP","volume":"9","author":"Amanzadeh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2024.101057_bib136","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.foodchem.2013.10.095","article-title":"Flavonoid metabolites transport across a human BBB model","volume":"149","author":"Faria","year":"2014","journal-title":"Food Chem."},{"key":"10.1016\/j.jpha.2024.101057_bib137","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpha.2024.101057_bib138","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: Bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jpha.2024.101057_bib139","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","article-title":"Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics","volume":"128","author":"Bourganis","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpha.2024.101057_bib140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejps.2003.10.012","article-title":"The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats","volume":"21","author":"Bagger","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpha.2024.101057_bib141","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","article-title":"Delivery of therapeutic agents to the central nervous system: The problems and the possibilities","volume":"104","author":"Begley","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jpha.2024.101057_bib142","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.addr.2016.01.010","article-title":"Oral delivery of macromolecular drugs: Where we are after almost 100years of attempts","volume":"101","author":"Moroz","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpha.2024.101057_bib143","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: A transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpha.2024.101057_bib144","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10717549709051878","article-title":"Delivery of 125I-NGF to the brain via the olfactory route","volume":"4","author":"Frey","year":"1997","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jpha.2024.101057_bib145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainres.2017.09.022","article-title":"Intranasally administered IGF-1 inhibits spreading depression in vivo","volume":"1677","author":"Grinberg","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.jpha.2024.101057_bib146","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/acel.12498","article-title":"Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe\/PS1dE9 mice","volume":"15","author":"Mao","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.jpha.2024.101057_bib147","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jpha.2024.101057_bib148","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.expneurol.2014.06.004","article-title":"Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces A\u03b2 level and microglia activation in the brains of 3xTg-AD mice","volume":"261","author":"Chen","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jpha.2024.101057_bib149","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3233\/JAD-159002","article-title":"Long acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s disease dementia","volume":"45","author":"Claxton","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpha.2024.101057_bib150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2017.11.037","article-title":"Intranasal insulin in Alzheimer\u2019s disease: Food for thought","volume":"136","author":"Chapman","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpha.2024.101057_bib151","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejpb.2019.12.014","article-title":"Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer\u2019s disease","volume":"148","author":"Akel","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpha.2024.101057_bib152","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.2147\/IJN.S305851","article-title":"Improving drug delivery for Alzheimer\u2019s disease through nose-to-brain delivery using nanoemulsions, nanostructured lipid carriers (NLC) and in situ hydrogels","volume":"16","author":"Cunha","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jpha.2024.101057_bib153","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2018.12.049","article-title":"Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis","volume":"295","author":"Costa","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpha.2024.101057_bib154","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","article-title":"Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies","volume":"11","author":"Costa","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpha.2024.101057_bib155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/10667857.2019.1575535","article-title":"Curcumin loaded TPGS micelles for nose to brain drug delivery: in vitro and in vivo studies","volume":"34","author":"Keshari","year":"2019","journal-title":"Mater. Technol."},{"key":"10.1016\/j.jpha.2024.101057_bib156","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/17425247.2014.919253","article-title":"Resveratrol: Review on therapeutic potential and recent advances in drug delivery","volume":"11","author":"Pangeni","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jpha.2024.101057_bib157","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/cts.13514","article-title":"Pharmacokinetics of intranasal amiloride in healthy volunteers","volume":"16","author":"Yellepeddi","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jpha.2024.101057_bib158","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2147\/IJN.S402447","article-title":"Nose to brain delivery of astaxanthin-loaded nanostructured lipid carriers in rat model of Alzheimer\u2019s disease: Preparation, in vitro and in vivo evaluation","volume":"18","author":"Shehata","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jpha.2024.101057_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/app10103353","article-title":"Formulation strategies to improve oral bioavailability of ellagic acid","volume":"10","author":"Zuccari","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.jpha.2024.101057_bib160","first-page":"299","article-title":"A novel nanoformulation of ellagic acid is promising in restoring oxidative homeostasis in rat brains with Alzheimer\u2019s disease","volume":"22","author":"Harakeh","year":"2021","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jpha.2024.101057_bib161","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.carbpol.2018.07.054","article-title":"Box-Behnken design optimization of mucoadhesive chitosan-coated nanoemulsions for rosmarinic acid nasal delivery \u2013 In vitro studies","volume":"199","author":"Fachel","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jpha.2024.101057_bib162","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2006.04.001","article-title":"Development of vitamin loaded topical liposomal formulation using factorial design approach: Drug deposition and stability","volume":"320","author":"Padamwar","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpha.2024.101057_bib163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041438","article-title":"Using liposomes as carriers for polyphenolic compounds: The case of trans-resveratrol","volume":"7","author":"Bonechi","year":"2012","journal-title":"PLoS One"}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177924001540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177924001540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T12:52:44Z","timestamp":1738068764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177924001540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":163,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2095177924001540"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2024.101057","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose to brain strategy coupled to nano vesicular system for natural products delivery: Focus on synaptic plasticity in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2024.101057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101057"}}